Reveals an association between remnant cholesterol and atherosclerotic disease in high-risk patients, indicating a residual pro-atherosclerotic role independent of LDL levels.
In a high-risk population, RC was associated with subclinical and clinically overt ASCVD, particularly in patients with the most adverse lipid phenotype (untreated) or in treated patients with a low LDL-related risk profile. These findings support a residual pro-atherosclerotic role of RC in high-risk patients.
No takes yet. Share an insight, caveat, or question.
Delialis et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: